Endovascular graft firm TriVascular has secured $60m in funding, which it will use to commercialise its Ovation abdominal stent graft system in Europe. The company closed a series C financing round, which was led by new investor Pinnacle Ventures. Existing investors New Enterprise ...
Please Login to read the full article.
